Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Drugs Made In America Acquisition II Corp

DMII ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Financials · Investment Holding Companies ·

USA Small Cap Analyst: N/A

Last Close

$10.15

▲ +0.00%

Market Cap $646.56M · Vol 101.79K

Key Metrics

P/E Ratio

12.56

FWD: N/A

Market Cap

$646.56M

Small Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

64.29

Momentum

Beta

N/A

vs Market

52W High

$10.19

0.39% below

52W Low

$9.87

2.84% above

Volume

101.79K

Avg 16.67K

P/B

0.28

Price-to-book

ROE

N/A

Return on equity

Free Float

84.79%

Public shares

Shariah Compliance8 STANDARDS

✗ Drugs Made In America Acquisition II Corp (DMII) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DMII pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.40%

+0.59%

+0.89%

+1.40%

YTD

+2.53%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$8.37M
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	3.32% · N/A

P/E Ratio	12.56
Forward P/E (FY1)	N/A
PEG Ratio	0.00
P/S	N/A
P/B	0.28
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	63.70M

Technical Indicators

50-Day SMA	$10.10
200-Day SMA	$N/A
RSI (14)	64.29
Beta	N/A
52-Week High	$10.19
52-Week Low	$9.87

Volume Today	101.79K
Avg Daily Volume (30D)	16.67K
Relative Volume	6.10x
Volatility (10D)	2.07
Volatility (30D)	1.91
Free Float	84.79%

Analyst Consensus

N/A

Current Price $10.15

Mean Target N/A

52W Low$9.87 52W High$10.19

Current

Target

$9.87 $10.19

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG01WC235D1

ISINKYG2851K1040

CountryUnited States of America

Sub-IndustryShell Companies

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2POINTZERO.AD Two Point Zero Group PJSC +1.95% LATO B.ST Investment AB Latour +0.43% REM.J Remgro Ltd -1.16% NCCI.KW National Consumer Holding Company KSCP -1.02% MUBARRAD.KW Mubarrad Holding Co KSCP -0.73%

Company Profile

Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. While the Company may pursue a business combination target in any business, industry or geographical location, it intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenue to date.